Gregory Segala

Chief Scientific Officer at FluoSphera SA

Speaker

Gregory Segala, PhD, is co-founder and Chief Scientific Officer of FluoSphera. He co-invented FluoSphera’s tissue multiplexing technology, which combines multiple 3D microtissues in a single well, and led the development of an assay to assess ADC-associated lung toxicity, particularly interstitial lung disease. His technology platform focuses on improving preclinical decision-making by identifying potential safety liabilities before clinical development